Conclusion
Randomized studies of PEP cannot be carried out for ethical and practical reasons. There are, however, many arguments supporting the use of anti-HIV PEP following ABE or sexual assault. States and health systems in resource-poor countries face the challenge of guaranteeing exposed HCWs and rape victims full-time and free-of-charge access to a physician capable of conducting a risk assessment, PEP drugs, and technical facilities for biologic assessment and serologic monitoring. Nonetheless, the use of HIV PEP in African countries must be supported and increased. Such efforts however, must also include the support and assurance of exposure prevention practices and a reduction in ABE incidence in health care settings. Likewise, efforts to reduce sexual violence worldwide must be stepped up.
While the number of occupationally infected HCWs is not in itself a public health crisis in comparison with the growing number of infections in the general population in Africa, ABE is a public health issue, as is the fear of occupational infection faced by ill-paid, ill-protected, and overworked HCWs in resource-poor countries. Providing prevention training, support, and free access to PEP is an ethical and fair measure that will help support HCWs in Africa in their continuing effort to provide quality care to an increasing number of HIV-infected patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Veeken H, Verbeek J, Houweling H, et al. Occupational HIV infection and health care workers in the tropics. Trop Doct, 1991;21:28–31.
de Graaf R, Houweling H, van Zessen G. Occupational risk of HIV among western health care professionals posted in AIDS endemic areas. AIDS Care, 1998;10:441–452.
Consten EC, van Lanschot JJ, Henny PC, et al. A prospective study on the risk of exposure to HIV during surgery in Zambia. AIDS, 1995;9:585–588.
Mann JM, Francis H, Quinn TC, et al. HIV sero-prevalence among hospital workers in Kinshasa, Zaire: lack of association with occupational exposure. JAMA, 1986;256:3099–3102.
N’Galy B, Ryder RW, BilaK, et al. Human immunodeficiency virus infection among employees in an African hospital. N Engl J Med, 1988;319:1123–1127.
Habitnana P, Bullterys M, Usabuwera P, et al. A survey of occupational blood contacts and HIV infection among traditional birth attendants in Rwanda. AIDS, 1994;8:701–704.
Diakhaté M, Diallo I, Sow PS, et al. Risques de transmission du VIH chez Jes accoucheuses traditionnelles au Sénégal. In: Abstracts of the Xth International Conference on AIDS and STDs in Africa; December 7–11, 1997; bidjan, Côte d’Ivoire. Abstract B245.
Du Plessis R, Webber L, Saymaan Q. Bloodborne viruses in forensic medical practice in South Africa. Am J Forensic Med Pathol, 1999;20:364–368.
Henderson DK, Fahey BJ, Willy M, et al. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures: a prospective evaluation. Ann Intern Med, 1990;113:740–746.
Public Health Laboratory Service. AIDS and STD at the Communicable Disease Surveillance Centre. Occupational transmission of HIV: Summary of published reports to June 1999. Public Health Laboratory Service, 1999:9–11.
Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med, 1997;337:1485–1490.
Gumudoka B, Favot I, Berege ZA, et al. Occupational exposure to the risk of HIV infection among health care workers in Mwanza Region, United Republic of Tanzania. Bull World Health Org, 1997;75:133–140.
Adegboye AA, Moss GB, Soyinka F, et al. The epidemiology of needlestick and sharp instrument accidents in a Nigerian hospital. Infect Control Hosp Epidemiol, 1994; 15:27–31.
Abiteboul D, Antona D, Fourrier A, et al. GERES. Exposition accidentelle au sang du personnel soignant. Resultats d’un an de surveillance du risque pour les infirmieres dans 17 hopitaux. Pathol Biol (Paris), 1992;40:983–989.
Johanet H, Antona D, Bouvet E, et le GERES. Risques d’exposition accidentelle au sang au bloc operatoire, Résultats d’une étude prospective multicentrique. Ann Chir, 1995;49:403–410.
Malachy O. Evaluation of a training workshop on HIV/AIDS for health care workers in Enugu and Anambra States of Nigeria. In: Abstracts of the Xth International Conference on AIDS and STDs in Africa; December 7–11, 1997; Abidjan, Côte d’Ivoire. Abstract B246.
Berkley S. Parenteral transmission of HIV in Africa. AIDS, 1991;5(Suppl 1):S87–S92.
Birungi H. Injections and self-help: risk and trust in Ugandan health care. Soc Sci Med, 1998;47:1455–1462.
Sagoe-Moses C, Pearson RD. Risks to health care workers in developing countries. N Engl J Med, 2001;345:538–541.
Simonsen L, Kane A, Lloyd J, et al. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Org, 1999;77:789–800.
Van de Perre P, Diakhate L, Watson-Williams J. Prevention of blood-borne transmission of HIV. AIDS, 1997;11(Suppl B):S89–S98.
Wyatt HV The popularity of infections in the third world: origins and consequences for poliomyelitis. Soc Sci Med, 1984;19:911–915.
Mast ST, Woolwine JD, Gerberding JL. Efficacy of gloves in reducing blood volumes transferred during simulated needlestick injury. J Infec Dis, 1993;168:1589–1592.
Bennett NT, Howard RJ. Quantity of blood inoculated in a needlestick injury from suture needles. JAm CollSurg, 1994;178:107–110.
Puro V, Petrosillo N, Ippolito G, et al. Update on occupational HCV infection incidence studies. In: Program and Abstracts of the International Colloquium on Bloodborne Infections; June 8, 1995; Paris, France. International Social Security Association Section for Health Services, 1995. Abstract PA8.
Alter HJ, Seeff LB, Kaplan PM, et al. Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med, 1976;295:909–913.
Grady GF, Lee VA, Prince AM, et al. Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis, 2002; 138:625–638.
Seeff LB, Wright EC, Zimmerman HJ, et al. Type B hepatitis after needle-stick exposures: Prevention with hepatitis B immune globulin: Final report of the Veteran’s Administration Cooperative Study. Ann Intern Med, 1978;88:285–293.
Gilks CF, Wilkinson D. Reducing the risk of nosocomial HIV infection in British health workers working overseas: role of post-exposure prophylaxis. BMJ, 1998;316:1158–1160.
Sow PS, Rachline A, Tarantola A, et al. pour les Correspondants du Réseau AES 3 Pays et le GERES. Connaissances et Practiques á Risque d’Accident Exposant au Sang (AES) chez les Soignants en Médecine dans 3 Pays d’Afrique de l’Ouest. Oral Presentation at the 12th International Conference on AIDS and STDs in Africa; December 8–13, 2001; Ouagadougou, Burkina Faso. Abstract 12BT3-4.
Centers for Disease Control and Prevention. Evaluation of blunt suture needles in preventing percutaneous injuries among health care workers during gynecologic surgical procedures—New York City, March 1993–June 1994. MMWR, 1997;46:25–29.
Gerberding JL, Littell C, Tarkington A, et al. Risk of exposure of surgical personnel to patients’ blood during surgery at San Francisco General Hospital. N Engl J Med, 1990;322:1788–1793.
Wright J, McGeer AJ, Chyatte D, et al. Mechanisms of glove tears and sharp injuries among surgical personnel. JAMA, 1991;266:1668–1671.
Matta H, Thompson AM, Rainey JB. Does wearing two pairs of gloves protect operating theater staff from skin contamination? BMJ, 1988;297:597–598.
Diarra J, Msellati P, Brissac M, et al. SIDA et personnel soignant en Côte d’Ivoire. Med Trop, 1996;56:259–263.
Russi M, Hajdun M, Barry M. A program to provide antiretroviral prophylaxis to health care personnel working overseas. JAMA, 2000;283:1292–1293.
N’Dri A, Boka Yao A, Ouattara Y, et al. Les accidents exposant au sang (AES) en milieu de soins: évaluation et prise en charge. In: Abstracts of the Xth International Conference on AIDS and STDs in Africa; December 7–11, 1997; Abidjan, Côte d’Ivoire. Abstract B969.
Gamester CF, Tilzey AJ, Banatvala JE. Medical students’ risk of infection with bloodborne viruses at home and abroad: questionnaire survey. BMJ, 1999;318:158–160.
Mastro TD, De Vincenzi I. Probabilities of sexual HIV-1 transmission. AIDS, 1996;10(Suppl A):S75–S82.
Downs A, De Vincenzi I, and the European study group in heterosexual transmission of HIV Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. J AIDS, 1996; 11:388–395.
Duerr A, Xia Z, Nagachinta T, et al. Probability of male-to-female HIV transmission among married couples in Chiang Maï, Thaïland. In: Abstracts of the Xth International Conference on AIDS; August 7–12, 1994; Yokohama, Japan. Abstract 105C.
Cameron DW, Simonsen JN, D’Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet, 1989;ii:403–407.
Mastro TD, Satten GA, Nopkesorn T, et al. Probability of female-to-male transmission of HIV-1 in Thailand. Lancet, 1994;343:852–853.
DeGruttola V Seage GR, Mayer KH, et al. Infectiousness of HIV between male homosexual partners. J Clin Epidemiol, 1989;42:849–856.
Vittinghoff E, Buchbinder SP, Judson F, et al. Percontact risk for transmission of HIV associated with four types of homosexual contact. In: Abstracts of the Vth Conference on Retroviruses and Opportunistic Infections; February 1–5, 1998; Chicago, IL, USA. Abstract 140.
Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med, 1993;328:327–335.
Tindall B, Evan L, Cunningham P, et al. Identification of HIV-1 in semen following primary HIV-1 infection. AIDS, 1992;6:949–952.
Saag MS, Grain MJ, Decker WD, et al. High-level viremia in adults and children infected with immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels. J Infect Dis, 1991;164:72–80.
Vernazza PL, Eron JJ, Cohen MS, et al. Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS, 1994;8: 1325–1329.
Vernazza PL, Gillian BL, Dyer J, et al. Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS, 1997; 11:987–993.
Royce RA, Sena A, Cates W, et al. Sexual transmission of HIV N Engl J Med, 1997;15:1072–1078
Halperin DT, Bailey RC. Male circumcision and HIV infection: 10 years and counting. Lancet, 1999;354:1813–1815.
Weiss H, Quigley M, Hayes R. Male circumcision and risk of infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS, 2000; 14:2361–2370.
Buve A. Male circumcision and spread of HIV in sub-Saharan Africa. In: Abstracts of the XIII International AIDS Conference; July 9–14, 2000; Durban, South Africa. Abstract MoOrl92.
Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and sexual transmission of human immunodeficiency virus type I. N Engl J Med, 2000; 342:921–929.
Dyer JR, Kazembe P, Vernazza PL, et al. High level of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis, 1998; 177:1742–1746.
Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect, 1999;75:3–17.
Bamberger JD, Waldo CR, Gerberding JL, et al. Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault. Am J Med, 1999; 106:323–327.
Ruprecht RM, Chou TC, Chipty F, et al. Interferon alpha and 3′ azido-3′ deoxythymidine are highly synergistic in mice and prevent viremia after acute retrovirus exposure. JAIDS, 1990;3:591–600.
Fazely F, Haseltine WA, Rodger RF, et al. Postexposure chemoprophylaxis with zidovudine or zidovudine combined with INF-α: failure after inoculating rhesus monkeys with a high dose of SIV. J AIDS, 1991;4:1093–1097.
Van Rompay KKA, Marthas ML, Ramos RA, et al. Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3′-azido-3′-deoxythymidine prevents SIV infection. Antimicrob Agents Chemother, 1992;36:2381–2386.
Van Rompay KKA, Otsyula MG, Marthas ML, et al. Immediate zidovudine treatment protects simian immunodeficiency virus infected newborn macaques against rapid onset of AIDS. Antimicrob Agents Chemother, 1995;39:125–131.
Tsai CC, Follis KE, Sabo A, et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl) adenine. Science, 1995;270:1197–1199.
Lifson JD, Lloyd A, Hirsch V, et al. Clues to primate lentiviral pathogenesis from the study of SIV viral dynamics. Paper presented at: Retroviruses of human AIDS and related animal diseases: XI Colloque des cents gardes; October 27–29, 1997; Paris, France.
Tsai CC, Emau P, Follis KE, et al. Effectiveness of postinoculation(R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol, 1998;72:4265–4273.
Bottiger D, Johansson NG, Samuelsson B, et al. Prevention of SIV, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre-and postexposure administration of BEA-005. AIDS, 1997;11:157–162.
Conner EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. NEnglJMed, 1994;331:1173–1180.
Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. NEnglJMed, 1996;335:1621–1629.
Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet, 1999;354:795–802.
Perdue B, Wolderufael D, Mellors J, et al. HIV-1 transmission by a needlestick injury despite rapid initiation of four-drug postexposure prophylaxis. In: Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. January 31-February 4, 1999; Chicago, Illinois, USA. Abstract 210.
Lot F, de Benoist AC, Abiteboul D. Infections professionnelles par le VIH en France chez le personnel de santé—le point au 30 juin 1998. Bull Epid Hebd, 1999:18:69–70.
Centers for Disease Control and Prevention. Guidelines for the Prevention of Transmission of Human Immunodeficiency Virus and Hepatitis B Virus to Health-Care and Public Safety Workers. MMWR, 1989;38(Suppl 6):1–37.
Centers for Disease Control and Prevention. Evaluation of Safety Devices for Preventing Percutaneous Injuries Among Health Care Workers During Phlebotomy Procedures—Minneapolis-St. Paul, New York City, and San Francisco, 1993–1995. MMWR, 1997;46:21–25.
Henderson DK. Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus. JAMA, 1999;281:931–936.
Clinical Effectiveness Group. National guideline for the management of adult victims of sexual assault. Sex Transm Inf, 1999;75(Suppl 1):S82–S84.
Bottomley CP, Sadler T, Welch J. Integrated clinical service for sexual assault victims in a genitourinary setting. SexTransmInf, 1999;75:116–119.
Jenny C, Hooton TM, Bowers A, et al. STDs in victims of rape. N Engl J Med, 1990;322:713–716.
Gostin LO, Lazzarini Z, Alexander D, et al. HIV test, counseling, and prophylaxis after sexual assault. JAMA, 1994;271:1436–1444.
Doumbia S, Tarantola A, Bouvet E for the West African Accidental Blood Exposure Surveillance Network and the GERES. Implementation of prospective accidental blood exposure surveillance systems in three western African countries. In: Abstracts of the XIII International AIDS Conference; July 9–14, 2000; Durban, South Africa. Abstract TuPeD3652.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Bouvet, E., Laporte, A., Tarantola, A. (2002). Postexposure Prophylaxis for Occupational Exposure and Sexual Assault. In: Essex, M., Mboup, S., Kanki, P.J., Marlink, R.G., Tlou, S.D., Holme, M. (eds) AIDS in Africa. Springer, Boston, MA. https://doi.org/10.1007/0-306-47817-X_37
Download citation
DOI: https://doi.org/10.1007/0-306-47817-X_37
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46699-1
Online ISBN: 978-0-306-47817-8
eBook Packages: Springer Book Archive